Irma Slavutsky

B, Argentina

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

IGLV3-21 subset #2 without IGLV3-21R110 in chronic lymphocytic leukemia, is it possible?

IGLV3-21 subset #2 without IGLV3-21R110 in chronic lymphocytic leukemia, is it possible?

Journal: Leukemia & lymphoma
Published: October 27, 2025

Double IGHV rearrangements in a Latin American cohort of chronic lymphocytic leukemia patients.

Double IGHV rearrangements in a Latin American cohort of chronic lymphocytic leukemia patients.

Journal: Leukemia research
Published: October 21, 2025

Single-nucleotide variants as potential prognostic biomarkers in newly diagnosed multiple myeloma patients.

Single-nucleotide variants as potential prognostic biomarkers in newly diagnosed multiple myeloma patients.

Journal: Hematology, transfusion and cell therapy
Published: July 14, 2025

Complex Karyotype in a Pediatric Patient with Double-Hit BCL6 High-Grade B-Cell Lymphoma.

Complex Karyotype in a Pediatric Patient with Double-Hit BCL6 High-Grade B-Cell Lymphoma.

Journal: Pediatric blood & cancer
Published: November 13, 2024

PD-L1/PD-L2 genetic profile in the molecular cytogenetic classification of classic Hodgkin lymphoma.

PD-L1/PD-L2 genetic profile in the molecular cytogenetic classification of classic Hodgkin lymphoma.

Journal: Virchows Archiv : an international journal of pathology
Published: October 24, 2024

Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants.

Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants.

Journal: Annals of hematology
Published: January 22, 2024

Survival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting.

Survival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting.

Journal: Current problems in cancer
Published: September 01, 2022

CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage.

CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage.

Journal: Leukemia & lymphoma
Published: November 16, 2021

Guiding the global evolution of cytogenetic testing for hematologic malignancies.

Guiding the global evolution of cytogenetic testing for hematologic malignancies.

Journal: Blood
Published: October 03, 2021

Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients.

Somatic hypermutation profiles in stereotyped IGHV4-34 receptors from South American chronic lymphocytic leukemia patients.

Journal: Annals of hematology
Published: March 05, 2021

A new dual translocation of chromosome 14 in a pediatric Burkitt lymphoma/leukemia patient: t(8;14) and t(14;15).

A new dual translocation of chromosome 14 in a pediatric Burkitt lymphoma/leukemia patient: t(8;14) and t(14;15).

Journal: Cancer genetics
Published: January 19, 2021

Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.

Frontline treatment with the combination obinutuzumab ± chlorambucil for chronic lymphocytic leukemia outside clinical trials: Results of a multinational, multicenter study by ERIC and the Israeli CLL study group.

Journal: American journal of hematology
Published: January 01, 2020
Showing 1-12 of 44

Last Updated: 09/26/2026